The Palico Private Equity Fund Marketplace
Nextech Invest Ltd. is a private equity general partner firm headquartered in Zurich, Switzerland.
Biopharmaceutical company Cleave Biosciences completed a $37m Series B financing round from Arcus Ventures, NEA, 5AM Ventures and others.
VC-backed Kura Oncology, a biopharmaceutical company focused on treating solid tumors and blood cancers, has raised $50m for its IPO.
Blueprint Medicines, an enzyme specialist backed by several VC firms, has launched its IPO on the NYSE raising $147m.
Read more news concerning Nextech Invest Ltd.
A sampling of Nextech Invest Ltd. portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?